Stocks Health care ALHC
NASDAQ · Health careAlignment Healthcare, Inc. (ALHC)
Alignment Healthcare, Inc. brought in $4.9B of revenue over the twelve months to September 30, 2026, up 35.9% from a year earlier. Net income was $28.9M, a net margin of 0.6%. Operating cash flow minus capital spending left $113.1M of free cash flow in fiscal 2025. At September 30, 2026 it held $727.7M in cash against $324.5M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on October 29, 2026.
Key facts about Alignment Healthcare, Inc.
- Net worth
- Alignment Healthcare, Inc. has a market value (market cap) of $1.6B at the latest share price, and shareholders' equity of $277.1M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $3.9B (+46.1% year on year), with a net loss of $724K. Over the 12 months to September 30, 2026: revenue $4.9B, net income $28.9M.
- Cash flow
- In fiscal 2025 operations brought in $139.9M of cash; after $26.8M of capital spending, free cash flow was $113.1M.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on October 29, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
- Next earnings report
- Alignment Healthcare, Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
What Alignment Healthcare, Inc. does
Alignment Healthcare, Inc. is registered with the SEC under industry code SIC 6324 (Hospital & Medical Service Plans). Its shares trade on NASDAQ under the ticker ALHC.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $3.9B | -$724K | $0.00 | $113.1M |
| 2024 | $2.7B | -$128M | -$0.67 | -$6.6M |
| 2023 | $1.8B | -$148M | -$0.79 | -$95.2M |
| 2022 | $1.4B | -$149.5M | -$0.83 | -$69.2M |
| 2021 | $1.2B | -$195.3M | -$1.14 | n/a |
| 2021 | $959.2M | -$22.9M | -$0.15 | n/a |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where ALHC ranks in Health care
Latest SEC filings
What Alignment Healthcare, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- November 5, 2026Passive stake changed SCHEDULE 13G/A
- October 29, 2026Quarterly report 10-Q · period to September 30, 2026Revenue rose 37% to $1.4B versus the same quarter last year; diluted EPS -$0.04 versus $0.02.
- October 29, 2026
- October 8, 2026
- October 5, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026Passive stake (5% or more) SCHEDULE 13G
- July 31, 2026Passive stake (5% or more) SCHEDULE 13G
- July 30, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 32% to $1.3B versus the same quarter last year; diluted EPS $0.17 versus $0.07.
- July 30, 2026
- July 27, 2026Passive stake changed SCHEDULE 13G/A
What is ALHC worth? A DCF from its reported cash flow
Insider trades
What the people running Alignment Healthcare, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders sold $9.6M worth of shares in the last 90 days and bought none on the open market. Most of the selling (79%) was pre-planned under Rule 10b5-1 trading plans.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 6, 2026 | Kim HyongChief Medical Officer | Sold | 32,479 | $269.6K |
| September 17, 2026 | Konowiecki Joseph SEVP, Corporate Affairs, Director | Sold | 23,511 | $202.4K |
| September 14, 2026 | Kao John EChief Executive Officer, Director | Soldpre-planned (10b5-1), indirect | 27,400 | $356.2K |
| September 11, 2026 | Kao John EChief Executive Officer, Director | Soldpre-planned (10b5-1) | 385,270 | $4.9M |
| September 11, 2026 | Maroney Dawn ChristinePresident | Sold | 122,707 | $1.6M |
| September 10, 2026 | Kao John EChief Executive Officer, Director | Soldpre-planned (10b5-1), indirect | 172,600 | $2.2M |
| August 14, 2026 | Maroney Dawn ChristinePresident | Soldpre-planned (10b5-1) | 5,000 | $70K |
| August 10, 2026 | Kao John EChief Executive Officer, Director | Soldpre-planned (10b5-1), indirect | 298,000 | $4.1M |
Who owns ALHC
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Wellington Management Group LLP13G, passive with 3 related filers | 8.4% | May 15, 2026 |
| Fmr LLC13G, passive with 1 related filers | 7.7% | February 5, 2026 |
| Qatar Investment Authority13G, passive with 1 related filers | 6.69% | September 24, 2025 |
| T. Rowe Price Investment Management, Inc.13G, passive | 6.2% | August 14, 2025 |
| Vanguard Portfolio Management13G, passive | 5.74% | July 31, 2026 |
| Warburg Pincus LLC13G, passive with 12 related filers | 5.28% | November 14, 2024 |
Largest institutional holders
Insiders
21 insiders reported holding 33,955,070 shares in total, about $260.4M at the last price.
| Holder | Shares |
|---|---|
| General Atlantic (ALN HLTH), L.P.10% owner | 13,476,58513,476,585 held indirectly |
| General Atlantic, L.P.10% owner | 13,476,58513,476,585 held indirectly |
| Kao John EChief Executive Officer, Director | 1,814,239590,766 held indirectly |
| Konowiecki Joseph SEVP, Corporate Affairs, Director | 1,080,305 |
| Maroney Dawn ChristinePresident | 794,606 |
| Scavo Robert L.Chief Information Officer | 487,685 |
| McClellan Mark B.Director | 370,531 |
| Joyce Christopher JChief Legal and Admin. Officer | 305,451 |
| Kosecoff Jacqueline BDirector | 303,963 |
| Kim HyongChief Medical Officer | 299,271 |
Questions about ALHC
What does Alignment Healthcare, Inc. do?
Alignment Healthcare, Inc. is a company in the Health care sector, listed on NASDAQ as ALHC. Its shares trade on NASDAQ under the ticker ALHC.
What is Alignment Healthcare, Inc.'s net worth?
Alignment Healthcare, Inc. has a market value (market cap) of $1.6B at the latest share price, and shareholders' equity of $277.1M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Alignment Healthcare, Inc. profitable?
Yes. Over the twelve months to September 30, 2026 it reported net income of $28.9M on revenue of $4.9B, a net margin of 0.6%.
How much revenue does Alignment Healthcare, Inc. make?
Over the twelve months to September 30, 2026 Alignment Healthcare, Inc. reported revenue of $4.9B. That is 35.9% more than a year earlier.
When did Alignment Healthcare, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on October 29, 2026. It covers the period to September 30, 2026. Its newest filing of any kind is the planned insider sale from November 9, 2026.
When is Alignment Healthcare, Inc.'s next earnings report?
Alignment Healthcare, Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Similar companies
Compare ALHC with
Follow ALHC
Get an email when Alignment Healthcare, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Alignment Healthcare, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.